SingHealth Duke-NUS Academic Medical Centre will NEVER ask you to transfer money over a call. If in doubt, call the 24/7 ScamShield helpline at 1799, or visit the ScamShield website at www.scamshield.gov.sg.

Background
The Communicable Diseases Agency (CDA) is launching the FY2026 Short-Term Fellowship call for applications to facilitate collaborative infectious disease (ID) research between healthcare and research institutions in Singapore and beyond. The fellowship will allow successful local ID researchers to:
All visits must be completed before 31 January 2027.
Funding Details
The fellowship award is up to S$10,000. This sum will include: Return economy airfare via the most direct route, daily allowance, airport transfer, travel insurance and/or visa fees, withholding tax (for Incoming Fellowships only).
Eligibility Criteria
Applicants should be ID researchers in a local institution who have demonstrated current active research (e.g., approved projects, awarded grants, publications) in the area of the proposed visit.
1Based on MFA guidelines.
Submission
Interested applicants are invited to complete the form and submit (i) a single Microsoft Word document (without signatures) and (ii) a single endorsed PDF document (with signatures and supporting documents e.g. quotations) through their Institutional Research Office to the Grant Secretariat (RCA_Grants@cda.gov.sg) by 27 March 2026 (Friday), 6pm.
Note: SingHealth applicants are to please refer to your respective Institutional Research Office for guidance on internal deadlines and submission procedures set by your institutions. Applications must be endorsed by the institutional authorities (e.g., Department Head, Director of Research or equivalent) to ensure institutional support, ownership, and oversight of the project.
Contact person
RCA Grant Secretariat: RCA_Grants@cda.gov.sg.
Additional Information
Please refer to the attached file for more information.
© 2026 Singapore Health Services Pte Ltd. All Rights Reserved.
Short-Term Fellowship - Application Form_FY2026